tiprankstipranks
Trending News
More News >
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
Canadian Market
Advertisement

Britannia Life Sciences Inc (BLAB) Ratios

Compare
2 Followers

Britannia Life Sciences Inc Ratios

TSE:BLAB's free cash flow for Q1 2025 was C$0.17. For the 2025 fiscal year, TSE:BLAB's free cash flow was decreased by C$ and operating cash flow was C$-4.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.09 0.26 0.92 0.42 0.25
Quick Ratio
3.09 0.24 0.92 0.42 0.25
Cash Ratio
2.32 0.13 0.57 0.20 0.08
Solvency Ratio
1.75 -0.28 0.43 -0.98 >-0.01
Operating Cash Flow Ratio
-1.43 0.20 0.26 0.34 -0.06
Short-Term Operating Cash Flow Coverage
-30.57 0.99 0.61 0.57 -0.07
Net Current Asset Value
C$ 3.89MC$ -12.86MC$ -8.27MC$ -12.12MC$ -16.27M
Leverage Ratios
Debt-to-Assets Ratio
0.19 0.33 0.36 0.25 0.49
Debt-to-Equity Ratio
0.33 2.99 1.20 3.84 -52.12
Debt-to-Capital Ratio
0.25 0.75 0.54 0.79 1.02
Long-Term Debt-to-Capital Ratio
0.22 0.66 0.47 0.08 1.09
Financial Leverage Ratio
1.77 9.13 3.35 15.59 -106.02
Debt Service Coverage Ratio
108.57 -0.54 2.44 -1.59 -0.23
Interest Coverage Ratio
15.31 0.13 0.21 0.16 0.32
Debt to Market Cap
0.12 0.61 0.54 0.24 6.47
Interest Debt Per Share
0.01 0.05 0.06 0.07 1.85
Net Debt to EBITDA
0.95 -3.15 0.84 -0.33 -6.01
Profitability Margins
Gross Profit Margin
92.66%64.12%72.43%72.08%82.24%
EBIT Margin
385.82%-29.39%104.81%-150.15%-118.42%
EBITDA Margin
371.55%-25.05%108.61%-147.55%-113.54%
Operating Profit Margin
206.88%2.29%2.78%5.20%8.06%
Pretax Profit Margin
372.30%-59.00%91.48%-181.84%28.12%
Net Profit Margin
-606.32%-62.99%79.39%-211.76%-11.03%
Continuous Operations Profit Margin
373.32%-58.11%91.45%-191.59%10.04%
Net Income Per EBT
-162.86%106.76%86.78%116.45%-39.23%
EBT Per EBIT
179.96%-2581.41%3295.78%-3497.28%348.90%
Return on Assets (ROA)
75.84%-21.42%21.59%-73.30%-0.73%
Return on Equity (ROE)
204.57%-195.58%72.39%-1142.96%77.68%
Return on Capital Employed (ROCE)
-35.41%1.47%0.94%2.97%1.02%
Return on Invested Capital (ROIC)
-34.54%1.22%0.84%2.26%0.21%
Return on Tangible Assets
75.84%-114.03%85.57%-383.50%-4.89%
Earnings Yield
53.95%-41.98%33.00%-74.30%-9.86%
Efficiency Ratios
Receivables Turnover
-6.09 6.26 4.01 4.07 0.84
Payables Turnover
-0.04 1.14 0.78 0.69 0.12
Inventory Turnover
0.00 14.73 0.00 0.00 80.69
Fixed Asset Turnover
-9.58 10.49 14.16 13.37 2.03
Asset Turnover
-0.13 0.34 0.27 0.35 0.07
Working Capital Turnover Ratio
-0.21 -1.86 -2.46 -1.17 -0.17
Cash Conversion Cycle
9.83K -238.26 -375.43 -440.89 -2.49K
Days of Sales Outstanding
-59.97 58.30 91.04 89.62 432.01
Days of Inventory Outstanding
0.00 24.78 0.00 0.00 4.52
Days of Payables Outstanding
-9.89K 321.34 466.47 530.52 2.93K
Operating Cycle
-59.97 83.07 91.04 89.62 436.53
Cash Flow Ratios
Operating Cash Flow Per Share
-0.02 0.01 <0.01 0.03 -0.10
Free Cash Flow Per Share
-0.02 0.01 <0.01 0.02 -0.09
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.05 0.84 0.72 0.97 0.93
Dividend Paid and CapEx Coverage Ratio
-19.22 6.20 3.55 32.15 -13.61
Capital Expenditure Coverage Ratio
-19.22 6.20 3.55 32.15 -13.61
Operating Cash Flow Coverage Ratio
-2.08 0.29 0.14 0.54 -0.06
Operating Cash Flow to Sales Ratio
3.08 0.28 0.19 0.38 -0.41
Free Cash Flow Yield
-28.85%15.44%5.68%13.04%-34.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.85 -2.38 3.03 -1.35 -10.14
Price-to-Sales (P/S) Ratio
-11.24 1.50 2.41 2.85 1.12
Price-to-Book (P/B) Ratio
2.49 4.66 2.19 15.38 -7.87
Price-to-Free Cash Flow (P/FCF) Ratio
-3.47 6.47 17.62 7.67 -2.93
Price-to-Operating Cash Flow Ratio
-3.65 5.43 12.66 7.43 -2.72
Price-to-Earnings Growth (PEG) Ratio
4.23 0.01 -0.02 >-0.01 0.10
Price-to-Fair Value
2.49 4.66 2.19 15.38 -7.87
Enterprise Value Multiple
-2.08 -9.13 3.05 -2.26 -6.99
Enterprise Value
9.48M 17.32M 21.21M 24.37M 11.31M
EV to EBITDA
-2.08 -9.13 3.05 -2.26 -6.99
EV to Sales
-7.72 2.29 3.31 3.34 7.94
EV to Free Cash Flow
-2.38 9.88 24.26 8.98 -20.81
EV to Operating Cash Flow
-2.51 8.28 17.44 8.70 -19.28
Tangible Book Value Per Share
0.03 -0.07 -0.04 -0.11 -2.64
Shareholders’ Equity Per Share
0.03 0.02 0.04 0.01 -0.03
Tax and Other Ratios
Effective Tax Rate
>-0.01 0.02 <0.01 -0.05 0.64
Revenue Per Share
>-0.01 0.05 0.04 0.07 0.24
Net Income Per Share
0.05 -0.03 0.03 -0.14 -0.03
Tax Burden
-1.63 1.07 0.87 1.16 -0.39
Interest Burden
0.96 2.01 0.87 1.21 -0.24
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
-1.15 0.43 0.53 1.84 0.53
Stock-Based Compensation to Revenue
0.00 0.03 0.16 0.15 -0.20
Income Quality
0.83 -0.44 0.21 -0.20 -4.10
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis